Detalhe da pesquisa
1.
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
J Urol
; 209(5): 882-889, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795962
2.
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer.
World J Urol
; 40(11): 2707-2715, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169695
3.
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer.
World J Urol
; 39(12): 4345-4354, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370078
4.
Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project).
World J Urol
; 38(1): 151-158, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30937569
5.
Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.
Invest New Drugs
; 37(6): 1231-1238, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231785
6.
Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer.
Invest New Drugs
; 37(3): 559-566, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31037562
7.
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group).
World J Urol
; 37(11): 2439-2450, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734072
8.
Current Paradigm for Ischemia in Kidney Surgery.
J Urol
; 195(6): 1655-63, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26804756
9.
Decline in renal function after partial nephrectomy: etiology and prevention.
J Urol
; 193(6): 1889-98, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25637858
10.
Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).
Mol Cancer
; 13: 70, 2014 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24655592
11.
Poorly functioning kidneys recover from ischemia after partial nephrectomy as well as strongly functioning kidneys.
J Urol
; 192(3): 665-70, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24657801
12.
Predictors of precision of excision and reconstruction in partial nephrectomy.
J Urol
; 192(1): 30-5, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24373802
13.
Compensatory hypertrophy after partial and radical nephrectomy in adults.
J Urol
; 192(6): 1612-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24931802
14.
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.
Eur Urol Open Sci
; 63: 71-80, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572300
15.
Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy.
Eur Urol Oncol
; 7(1): 112-121, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468393
16.
Comparative outcomes of laparoscopic and open adrenalectomy for adrenocortical carcinoma: single, high-volume center experience.
Ann Surg Oncol
; 20(5): 1456-61, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23184291
17.
Oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma: a literature review.
Transl Androl Urol
; 12(8): 1351-1362, 2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37680219
18.
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
Front Oncol
; 13: 1113246, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37064092
19.
The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy.
Can Urol Assoc J
; 17(10): 301-309, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851909
20.
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis.
Eur Urol
; 81(4): 414-425, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101302